22Jan
Healthcare Antitrust – What to Expect in 2021
The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the announcement of the precedent-setting settlement of the California Attorney General’s action against Sutter Health and ended with the settlement of multi-district antitrust litigation against the Blue Cross Blue Shield Association (and its member Blues)....
By:
Akerman LLP - Health Law Rx
Related
One effect of the COVID-19 pandemic has been to accelerate the implementation of new or stricter con...
Read More >
By a 9-0 vote, the U.S. Supreme Court ruled today that by and large, the courts should continue defe...
Read More >
The DOJ’s Antitrust Division announced updates late last week to its Civil Investigative Demand (CI...
Read More >
In the wake of COVID-19 and the mass telework directives, the Premerger Notification Office of the F...
Read More >
Le 25 novembre 2020, la Cour de cassation a opéré un revirement de jurisprudence important pour la p...
Read More >
As the end of the year approaches, there are several legal considerations and tasks that businesses ...
Read More >